Quantification of serum hepatitis B surface antigen in predicting the response of pegylated interferon alfa-2a in HBeAg-positive chronic hepatitis B with prior lamivudine exposure

AIMS: Majority of previous studies of pegylated interferon α-2a (PegIFNα-2a) forced on naïve chronic hepatitis B (CHB) patients, and the data of PegIFNα-2a in therapy of patients with prior exposure to nucleos(t)ide analogues is rare. This study aimed to investigate the predictive role of serum quan...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Min, Zeng, Wei-Zheng, Wu, Xiao-Ling, Zhang, Yong, Jiang, Ming-De, Wang, Zhao, Zhou, De-Jiang, He, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848114/
https://www.ncbi.nlm.nih.gov/pubmed/24010768
http://dx.doi.org/10.1186/1743-422X-10-277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848114/
https://www.ncbi.nlm.nih.gov/pubmed/24010768
http://dx.doi.org/10.1186/1743-422X-10-277

Ejemplares similares